University of Ioannina
Δράση του φυτού βαλσαμόχορτο (Hypericum perforatum) στον καρκίνο της ουροδόχου κύστης
Abstract
dc:descriptionAim of the current thesis is the systematic and in depth research of the anticancer activity of St John’s wort (Hypericum Perforatum) against bladder cancer. With the help of reverse phase high performance liquid chromatography (RP-HPLC) hyperforin (2,36 ± 0,03 mg/g) was identified as major constituent of the aqueous extract recommended by the traditional medicine in the rural area of Epirus/ Greece. Male BULBc mice were exposed to 1000ppm OH-BBN in drinking water every other day for 6weeks. They were sacrificed after 26 weeks. The aqueous extract reachedstatistical significant anticancer effect (Fisher’s exact test p=0.048) administrated for 26 weeks after the carcinogen was induced, causing a 43,6% reduction in precancerous and cancer lesions. On the contrary concomitant administration with OH-BBN showed no statistical benefit (Fisher’s exact test p=0.093). Then we proceeded to search for the most active derivative of the plant, either as solutions or in the form of extracts or after fractionation. The components were analyzed by RP-HPLC. Anticancer activity was evaluated against T24 and NBT-II bladder cancer cell lines in the dark. The sixth Petroleum Ether Extract’s Fraction (PEE6) was the most effective. In search of the components responsible for the antitumor activity it was found that this is not due to hyperforin but unknown substances that could not be identified in the given time. TUNEL test has shown thatcell death occurs through apoptosis. From the physicochemical analysis of the extracts it was found that the Polar Methanolic Fraction (PMF), a powder containing only 0.57% hypericin, has sameemission and absorption spectra as pure hypericin, is water soluble and stable at room temperature making it an interesting photosensitizer for further study. We compared the PMF at various concentrations with Photofrin®, an FDAapproved photodynamic therapy (PDT) substance after excitation with 630 nm laser light against T24 and RT4 bladder cancer cell lines. The photosensitizer exhibited significant photocytotoxicity in both cell lines, cell destruction from 80% to 86%respectively, at a concentration of 60microg/ml and energy 4-8 J/cm2. Photofrin® exhibited photocytotocixity (77%) in the T24 cell line only. We compared white light sources for photoactivation of PMF against T24 cells. The most effective was a halogen Storz 482 Cold Light Fountain. Experimenting with female Wistar rats at various doses of intravesical PMF with staggered intravesical instillation times and various excitation energies we concluded to a dosage of 36.5mg / ml PMF, fifteen minute intravesical instillation and 700J / cm2 white light photoactivation. Based on the above, we proceeded with an experimental model of orthotopic implantation of AY27 tumor cells. We had complete (100%) elimination of superficial cancerous lesions as well as normal urothelium at 30 days’ post-treatment. Urothelium is fully regenerated, without scarring, 90 days after photodynamic therapy.In conclusion Hypericum Perforatum aqueous extract has statistical significantanticancer action when administrated after the carcinogen exposure. The antitumoractivity observed by PEE6 in vitro is attributed to substances currently unknown. PMFexhibits significant antitumor activity both in vitro, after stimulation with 630nm laserlight or white light, and in vivo, with complete elimination of the cancer lesions withoutthe appearance of scars on the bladder with fully regenerated urothelium after 90days.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsimaris, Ioannis
- Τσίμαρης, Ιωάννης
Subjects
dc:subject × 23- Βαλσαμόχορτο
- Υπερικίνη
- Ψευδοϋπερικίνη
- Υπερφορίνη
- Καρκίνος ουροδόχου κύστης
- Φωτοδυναμική θεραπεία
- Φθορισμός
- Αντικαρκινική δράση
- St John's wort
- Hypericum perforatum
- Hypericin
- Pseudohypericin
- Hyperforin
- Bladder cancer
- Photodynamic therapy
- Fluorescence
- Anticancer activity
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Basic Medicine
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48178